SCHEMBL2646543

SCHEMBL2646543

Clc1cccnc1Oc1ccc2ncnc(Nc3nccs3)c2c1.Cn1ccc(Nc2ncnc3ccccc23)n1

nearest known ligand 0.79

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GCK P35557 20/20 0.79

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2660365 0.89 GCK (1.00) GCK
SCHEMBL2642443 0.86 GCK (0.62) GCK
SCHEMBL2642301 0.79 GCK (0.80) GCK
SCHEMBL2642428 0.78 GCK (1.00) GCK
SCHEMBL2642583 0.78 GCK (1.00) GCK
SCHEMBL2642419 0.76 GCK (0.78) GCK
SCHEMBL2642176 0.76 GCK (0.78) GCK
SCHEMBL2642277 0.76 GCK (0.83) GCK
SCHEMBL2642606 0.76 GCK (0.75) GCK
SCHEMBL2642335 0.76 GCK (0.71) GCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7687502-B2 Substituted quinazoline or pyridopyrimidine derivative BANYU PHARMACEUTICAL CO., LTD. (JP) 2010-03-30 US disclosed
EP-1734040-A1 SUBSTITUTED QUINAZOLINE OR PYRIDOPYRIMIDINE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 2006-12-20 EP disclosed